Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity.

Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Abstract Text:

    shuai chenShuai Chen,xuemei zhaoXuemei Zhao,jinzhi tanJinzhi Tan,hong luHong Lu,zhi qiZhi Qi,qiang huangQiang Huang,xianzhuo zengXianzhuo Zeng,mingjun zhangMingjun Zhang,shibo jiangShibo Jiang,hualiang jiangHualiang Jiang,long yuLong Yu,

    Cyclophilin A acts as protein folding chaperones and intracellular transports in many cellular processes. Previous studies have shown that cyclophilin A can interact with HIV-1 (human immunodeficiency virus type 1) gag protein and enhance viral infectivity. Many cyclophilin A inhibitors such as cyclosporin A can inhibit HIV-1 replication in vitro. Here, we report a structure-based identification of novel non-peptidic cyclophilin A inhibitors as anti-HIV lead compounds. Following a computer-aided virtual screening and subsequent surface plasmon resonance (SPR) analysis, 12 low molecular weight cyclophilin A ligands were selected for further evaluation of their in vitro inhibition of peptidyl-prolyl cis-trans isomerase (PPIase) activity of cyclophilin A and HIV-1 replication. Five of these compounds (FD5, FD8, FD9, FD10 and FD12) exhibited inhibition against both PPIase activity and HIV-1 infection. These active compounds will be used as leads for structure and activity relationship (SAR) and optimization studies in order to design more effective anti-HIV-1 therapeutics, and as probes for investigating the effect of cyclophilins on HIV-1 replication.

    Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Publishing Authors By Initials

    s chenS Chen,x zhaoX Zhao,j tanJ Tan,h luH Lu,z qiZ Qi,q huangQ Huang,x zengX Zeng,m zhangM Zhang,s jiangS Jiang,h jiangH Jiang,l yuL Yu,

    For similar biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: viral physiology: virus replication research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: viral physiology: virus replication research

    PUBMED ID PMID:

    MEDLINE DATE:

    Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: European journal of pharmacology

    VOLUME: 565

    Page Numbers: 54-9

    Journal Abbreviation: Eur. J. Pharmacol.

    ISSN: 0014-2999

    DAY: 24

    MONTH: 03

    YEAR: 2007

    Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1254354

    Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Keywords Mesh Terms:

    KEYWORDS: Virus Replication

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Information

    Substance Name: Peptidylprolyl Isomerase

    Registry Number: EC 5.2.1.8

    Grant and Affiliation Information for Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity.

    AFFILIATION: State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, People's Republic of China.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY: United States NIAID

    GRANT: AI46221

    ACRONYM: AI

    MEDLINETA: Eur J Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News